Groundbreaking gene therapy restores vision to two men
Groundbreaking gene therapy has restored vision to two men with a rare inherited eye disease who were expected to go blind.
Groundbreaking gene therapy has restored vision to two men with a rare inherited eye disease who were expected to go blind.
Preliminary results from the first six patients taking part in a Phase One trial surprised and delighted the Oxford University team.
Although the trial was only designed to test safety and dosages, two men with relatively advanced disease experienced dramatic improvements to their eyesight.
The researchers are now planning a larger Phase II trial that will focus on the therapy's effectiveness.
The Democratic presidential candidate may also have shown his cards on his choice of running mate.
The US president also shared a post on Twitter accusing Dr Anthony Fauci of misleading the public over hydroxychloroquine.
Fears over an impending second wave of coronavirus dominates Wednesday’s front pages.